Relationship of Test Positivity Rates with COVID-19 Epidemic Dynamics.
COVID-19
SARS-CoV-2
effective reproduction number
epidemics
laboratory diagnosis
outbreaks
pandemic
surveillance
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
27 04 2021
27 04 2021
Historique:
received:
07
04
2021
revised:
23
04
2021
accepted:
24
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
6
5
2021
Statut:
epublish
Résumé
Detection and isolation of infected people are believed to play an important role in the control of the COVID-19 pandemic. Some countries conduct large-scale screenings for testing, whereas others test mainly people with high prior probability of infection such as showing severe symptoms and/or having an epidemiological link with a known or suspected case or cluster of cases. However, what a good testing strategy is and whether the difference in testing strategy shows a meaningful, measurable impact on the COVID-19 epidemic remain unknown. Here, we showed that patterns of association between effective reproduction number (Rt) and test positivity rate can illuminate differences in testing situation among different areas, using global and local data from Japan. This association can also evaluate the adequacy of current testing systems and what information is captured in COVID-19 surveillance. The differences in testing systems alone cannot predict the results of epidemic containment efforts. Furthermore, monitoring test positivity rates and severe case proportions among the nonelderly can predict imminent case count increases. Monitoring test positivity rates in conjunction with the concurrent Rt could be useful to assess and strengthen public health management and testing systems and deepen understanding of COVID-19 epidemic dynamics.
Identifiants
pubmed: 33925665
pii: ijerph18094655
doi: 10.3390/ijerph18094655
pmc: PMC8125747
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 16809810
Références
Nat Biotechnol. 2020 Aug;38(8):932-933
pubmed: 32704170
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Jpn J Infect Dis. 2020 Nov 24;73(6):491-493
pubmed: 32611985
Nat Biotechnol. 2020 Jun;38(6):653
pubmed: 32493981
Nat Med. 2021 Feb;27(2):183
pubmed: 33542537
Lancet. 2021 Apr 3;397(10281):1265-1275
pubmed: 33773118
JAMA Intern Med. 2021 Jul 1;181(7):913-921
pubmed: 33821922
Science. 2020 Jul 24;369(6502):413-422
pubmed: 32532802
Lancet Infect Dis. 2020 Oct;20(10):1105-1106
pubmed: 32559453
BMJ. 2020 Aug 20;370:m3262
pubmed: 32819920
Am J Epidemiol. 2013 Nov 1;178(9):1505-12
pubmed: 24043437
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
Nat Hum Behav. 2020 Sep;4(9):964-971
pubmed: 32759985
BMJ. 2020 Sep 4;370:m3379
pubmed: 32887691
Clin Epidemiol Glob Health. 2021 Jan-Mar;9:157-161
pubmed: 32869006
Nat Commun. 2020 Nov 20;11(1):5917
pubmed: 33219229
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
JAMA Intern Med. 2021 Apr 1;181(4):450-460
pubmed: 33231628
Nat Immunol. 2021 Mar;22(3):262-263
pubmed: 33627881
J Epidemiol. 2021 Jun 5;31(6):387-391
pubmed: 33814508
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
Lancet Infect Dis. 2020 Dec;20(12):1381-1389
pubmed: 32822577
Chaos Solitons Fractals. 2020 Oct;139:110059
pubmed: 32834612
Science. 2021 Jul 16;373(6552):
pubmed: 34083451
Cell Host Microbe. 2021 Apr 14;29(4):503-507
pubmed: 33676588
Nature. 2020 Jul;583(7816):346-348
pubmed: 32620883
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32521222
BMJ. 2020 Nov 3;371:m4268
pubmed: 33144291
Lancet Infect Dis. 2021 Jun;21(6):793-802
pubmed: 33743847
Science. 2020 Aug 7;369(6504):624-626
pubmed: 32764055
Lancet Microbe. 2020 Jul;1(3):e103-e104
pubmed: 32835338